Biogen pays $120 million for late-stage stroke treatment Cirara
admin 17th May 2017 Uncategorised 0Strikes licensing deal with Remedy Pharmaceuticals
More: Biogen pays 0 million for late-stage stroke treatment Cirara
Source: News
Strikes licensing deal with Remedy Pharmaceuticals
More: Biogen pays 0 million for late-stage stroke treatment Cirara
Source: News
© 1994 - 2024 B.M. Pharmaceuticals